Target intelligence / Profile preview

Probable guanine nucleotide exchange factor MCF2L2 (MCF2L2)

Target
MCF2L2
Molecular classification
Enzyme, Guanine nucleotide exchange factor (GEF), Rho guanine nucleotide exchange factor (ARHGEF) family
01

Overview

MCF2L2, also known as probable guanine nucleotide exchange factor MCF2L2, is a member of the Rho guanine nucleotide exchange factor (RhoGEF) family, classified as an enzyme that catalyzes the activation of Rho family GTPases by promoting the exchange of GDP for GTP[3][7]. Rho family GTPases act as molecular switches in a variety of intracellular signaling pathways affecting cytoskeletal reorganization, cell migration, adhesion, morphogenesis, and neuronal development[2][4]. As with other GEFs, MCF2L2 likely has a role in modulating cell behavior via activation of Rho GTPases, although specific substrates or detailed mechanistic studies for MCF2L2 are limited. While GEFs can be implicated in cancer and neurodevelopmental disorders (by analogy with characterized family members), direct therapeutic targeting or drug interactions for MCF2L2 itself are not well documented[6][7].

Other names
ARHGEF22Dbs-related Rho family guanine nucleotide exchange factorMCF2-transforming sequence-like protein 2KIAA0861DRGputative guanine nucleotide exchange factor MCF2L2MF2L2
02

Biological functions

Signal transductionRegulation of Rho family GTPasesCytoskeletal organizationNeuronal differentiation and development (by analogy with Trio/Dbl-related GEFs)Cell proliferation
03

Disease associations

Cancer (GEFs including MCF2L2 paralogs are implicated in tumorigenesis)Neurodevelopmental disease (GEFs play a role in the nervous system)Microphthalmia, syndromic 3 (OMIM 619946)

Beyond the preview

Go deeper on Probable guanine nucleotide exchange factor MCF2L2 (MCF2L2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable guanine nucleotide exchange factor MCF2L2 (MCF2L2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call